SCHEMBL24797141

SCHEMBL24797141

COc1cc(O)c(C(O)c2ccccc2)c(S(=O)(=O)O)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.42
▸ MAPT P10636 3/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ HPGD P15428 2/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ CYP3A4 P08684 2/20 0.42
▸ USP2 O75604 1/20 0.42
▸ TP53 P04637 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ TRPV1 Q8NER1 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ LMNA P02545 2/20 0.40
▸ MPL P40238 2/20 0.38
▸ PDE10A Q9Y233 1/20 0.38
▸ CYP2C19 P33261 3/20 0.37
▸ CYP2C9 P11712 2/20 0.37
▸ CYP19A1 P11511 1/20 0.37
▸ MAOA P21397 1/20 0.37
▸ MAOB P27338 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3830875 0.73 MAPT (0.55) ALDH1A1MAPTKMT2AHPGDKDM4E
SCHEMBL13370040 0.72 LMNA (0.58) ALDH1A1MAPTKMT2AHPGDKDM4E
Ammonia Solution, Strong SCHEMBL9618535 0.72 MAPT (0.54) ALDH1A1MAPTKMT2AHPGDKDM4E
SCHEMBL17656483 0.71 CNR2 (0.49) ALDH1A1MAPTKMT2AKDM4EMEN1
SCHEMBL4819668 0.69 BRD4 (0.57) ALDH1A1MAPTKMT2AMEN1SMN1; SMN2
SCHEMBL3823999 0.69 TYR (0.52) ALDH1A1MAPTHPGDCYP3A4LMNA
SCHEMBL14677163 0.69 TDP1 (0.46) MAPTKMT2AKDM4EMEN1CYP3A4
SCHEMBL8083576 0.68 MAPT (0.41) ALDH1A1MAPTKMT2AHPGDKDM4E
SCHEMBL2336447 0.68 ERN1 (0.50) ALDH1A1MAPTKMT2AHPGDKDM4E
SCHEMBL1155621 0.68 NPC1 (0.52) ALDH1A1MAPTKMT2AHPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11535647-B2 Peptide purification method using sulfonate compound NAGASE & CO., LTD. (JP) 2022-12-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11535647-B2 Peptide purification method using sulfonate compound VIP, IAPP, RPS27A ALDH1A1 4729/4885MAPT 2693/4885KMT2A 3412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback